Home › Research › Topics › peptidase-4-inhibitors
peptidase-4-inhibitors
3 studies tagged peptidase-4-inhibitors, dated 2019-05-08 to 2020-04-16. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus: a systematic review and meta-analysis 2020-04-16
- The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice 2019-05-23
- Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders; A Mini-Review With Special Focus on Linagliptin and Stroke 2019-05-08
Studies
3 studies carry this tag.
Date range
2019 to 2020
Top journals
- Acta diabetologica 1
- Frontiers in neurology 1
- International journal of molecular sciences 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Currently there is not enough irrefutable evidence to support the hypothesis of positive effects of incretins on cognition.
-
Vascular risk factors, such as type 2 diabetes mellitus (T2DM), are associated with the increased risk of Alzheimer's disease.
-
Cerebral stroke is a leading cause of death and persistent disability of elderly in the world.